Annual Congress Vienna 2009

Saturday, 12.09.2009
Sunday, 13.09.2009
Monday, 14.09.2009
Tuesday, 15.09.2009
Wednesday, 16.09.2009

Citations should be made in the following way: Authors. Title. Eur Respir J 2009; 34: Suppl. 53, abstract number.

Material from 2009:

4047 Abstracts
652 Slide presentations
300 Webcasts
93 Handouts
2150 e-posters
300 Multimedia files

Material from 2009: Show

Clinical Trial "PDEIV inhibitors in the treatment of COPD - the Roflumilast Trials"

Symposium
Chairs: T. Welte (Hanover, Germany), B. Lipworth (Dundee, United Kingdom)
Aims: To determine whether using the PDEIV inhibitor Roflumilast improves lung function and reduces exacerbation frequency in selected groups of COPD patients. To establish whether this effect was independent of therapy with long-acting bronchodilators.

Download all media

Roflumilast treatment over one year – the AURA and HERMES trials F. Martinez (Ann Arbor, Mi, United States of America)